Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Tel: USA-760-579-0393 Toll free: 888-462-4959 Fax: USA-760-579-0394 [email protected] http://globozymes.com PRODUCT DATASHEET cRaf-1 cRaf-1 is a protein serine/threonine kinase which plays a central role in the mitogenic response of cells to growth factors, cytokines, and many oncogenes. The kinase has been implicated as a pivotal regulator of endothelial cell survival during angiogenesis. It may also have a role in antineoplastic drug resistance. Inhibition of phosphorylation of Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel, a natural product which has significant anti-tumor activity particularly in advanced ovarian and breast carcinomas. Raf-1is activated through both Ras-dependent and Ras-independent mechanisms. Once activated, Raf-1 phosphorylates and activates the dual specificity protein kinases MEK1 and MEK2 which in turn phosphorylate and activate the serine/threonine specific MAP kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors and play an important role in the control of diverse cellular processes. The protein kinase activity of c-Raf-1 is strongly influenced by two key tyrosine residues upstream of the ATP binding site (Y340 and Y341). Dephosphorylation of Ser259 by protein phosphatase 2A (GLO130-GLO132) contributes to Raf-1 activation by supporting its membrane accumulation rather than by increasing the specific activity of the kinase. Phosphorylation of Raf-1 by PAK1 (GLO100-001, GLO100-005) and Src regulates Raf-1 autoinhibition. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Catalog GLO115-100 Price/vial $378.00 Source GST-tagged recombinant human produced in E. coli Purity > 80% by SDS-PAGE. Supplied 100 ng in 50 ml 50 mM Tris-HCl pH 7.0 buffer containing 14 mM b-mercaptoethanol, 1 mM benzamidine, 0.1 mM phenylmethanesulfonyl fluoride, 1 mM EDTA and 50% glycerol. Activity 20 units/mg with MEK as substrate. One unit of c-raf-1 is the amount of the enzyme that generates one unit of MAP kinase per minute. One unit of MAP kinase is the amount that incorporates 1 nmol of phosphate into myelin basic protein (MBP, GLO126-010, GLO126-025) per min at 30 EC, pH 7.0. Storage Maintain preparations in aliquots at -70 EC. Avoid repeated thawing. References: Bonner TI et al (1985) “Structure and biological activity of human homologs of the raf/mil oncogene” Mol Cell Biol 5, 1400; Stokoe D et al (1994) “Activation of Raf as a result of recruitment to the plasma membrane” Science 264, 1463; Alessi DR et al (1995) “Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf” Methods Enzymol 255, 2792; Bosch E et al (1997) Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1" Oncogene 15, 1021; Coles LC et al (2002) “PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway” Oncogene 21, 2236; Kubicek M (2002) “Dephosphorylation of Ser-259 regulates Raf-1 membrane association” J Biol Chem 277, 7913; Lee M et al (2003) “Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells” Cancer Lett 193, 57; Mabuchi S et al (2002) “Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel” J Biol Chem 277, 33490; Tran NH & Frost JA (2003) “Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition” J Biol Chem 278, 11221 GloboZymes products are for basic science research purposes only. They are not intended for human drug, food additive, clinical or household use.